d) Thrombolytics and Low Molecular Weight Heparins

Probably

ASSENT-3 appears to show that tenecteplase in combination with enoxaparin reduced the frequency of ischemic complications compared with unfractionated heparin. The increased rate of bleeding was not statistically significant in the enoxaparin group (18). HART II found that Enoxaparin was as effective as unfractionated heparin when combined with thrombolytics (19).

There may be more than one correct answer for this decision point.